BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathur K, Vuppalanchi V, Gelow K, Vuppalanchi R, Lammert C. Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis. Dig Dis Sci 2020;65:322-8. [PMID: 31363952 DOI: 10.1007/s10620-019-05756-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kudrich C, Hurd YL, Salsitz E, Wang AL. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol. Cannabis Cannabinoid Res 2021. [PMID: 34678050 DOI: 10.1089/can.2021.0089] [Reference Citation Analysis]
2 Vuppalanchi V, Gelow K, Green K, Vuppalanchi R, Lammert C. Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic. J Investig Med 2021:jim-2021-001871. [PMID: 34315800 DOI: 10.1136/jim-2021-001871] [Reference Citation Analysis]
3 Holloman BL, Nagarkatti M, Nagarkatti P. Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. Int J Mol Sci 2021;22:7302. [PMID: 34298921 DOI: 10.3390/ijms22147302] [Reference Citation Analysis]
4 Pennypacker SD, Romero-Sandoval EA. CBD and THC: Do They Complement Each Other Like Yin and Yang? Pharmacotherapy 2020;40:1152-65. [PMID: 33080058 DOI: 10.1002/phar.2469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gelow K, Chalasani S, Green K, Lammert C. Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients. Dig Dis Sci 2021. [PMID: 34160734 DOI: 10.1007/s10620-021-07112-0] [Reference Citation Analysis]